## Investigation of Choice for Brugada Syndrome Risk Stratification **Key Point:** Electrophysiological study (EPS) with programmed ventricular stimulation is the most specific investigation for assessing arrhythmia inducibility and guiding ICD implantation in Brugada syndrome. ### Brugada Syndrome Pathophysiology Brugada syndrome is caused by mutations in **SCN5A** (sodium channel gene, similar to LQT3) or other genes affecting the Na^+^ channel function. This results in: 1. **Loss of function of L-type Na^+^ channels** → reduced inward Na^+^ current during phase 0 2. **Unopposed outward K^+^ current** in the epicardium (due to Ito channel) → phase 1 "spike-and-dome" morphology 3. **Transmural voltage gradient** → ST-segment elevation in V1–V3 (Brugada ECG pattern) 4. **Reentry substrate** → ventricular fibrillation risk ### Why EPS is the Gold Standard for Risk Stratification **High-Yield:** Programmed ventricular stimulation (PVS) assesses: - **Inducibility of ventricular fibrillation** with one or two extrastimuli - **Refractory period properties** of the ventricle - **Substrate vulnerability** to reentry | Finding | Clinical Significance | | --- | --- | | Inducible VF with ≤2 extrastimuli | High risk; ICD indicated | | Non-inducible VF | Lower risk; medical management may suffice | | Inducibility with 3+ extrastimuli | Intermediate risk; shared decision-making | **Clinical Pearl:** Patients with: - **Spontaneous Type 1 Brugada ECG pattern** + **inducible VF on EPS** → **ICD strongly recommended** - **Asymptomatic with Type 1 pattern** + **non-inducible on EPS** → **ICD deferred, close monitoring** - **Symptomatic (syncope/VF)** → **ICD indicated regardless of EPS result** ### Mechanism: How EPS Identifies Arrhythmia Risk Programmed stimulation reproduces the reentrant circuit that underlies ventricular fibrillation in Brugada syndrome. The ability to induce VF with minimal extrastimuli indicates a vulnerable substrate and predicts future spontaneous arrhythmias. **Mnemonic:** **EPS = Electrophysiological Substrate** (directly assesses the reentry circuit) ## Why Other Investigations Are Insufficient **Holter monitoring** documents spontaneous arrhythmias but does not provoke the substrate or predict future risk in asymptomatic patients. **Stress testing** does not reliably induce VF in Brugada syndrome and may be dangerous; it is not used for risk assessment. **Cardiac CTA** is used for structural imaging but provides no electrophysiological information about arrhythmia substrate or inducibility.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.